MPJE Kansas Exam 2023

In Kansas, controlled substance records and inventories must be kept on file for
no less than? - ANSWER 5 years

How long must you keep records of drugs donated to indigent facilities? - ANSWER
5 years (keep manifest)

Label Requirements for non-controlled drugs (Federal) - ANSWER 1) name &

address of pharmacy

2) serial number of prescription

3) date of prescription issuance or date filled

4) name of prescriber

5) name of patient, if stated

6) directions for use, including precautions, as indicated on the prescription

7) "call your doctor for medical advice about side-effects. you may report side
effects to FDA at 1-800-FDA-1088." May distribute by: sticker attached to container,
pre-printed prescription vial cap, on a separate sheet of paper, in consumer
medication information, or in appropriate FDA-approved MedGuide.

Label Requirements for non-controlled drugs (Kansas) - ANSWER 1) name,

address, & telephone number of pharmacy

2) identification number of the prescription

3) date prescription filled or refilled

4) name of prescriber

5) full name of patient

6) adequate directions for use

7) beyond-use date

8) brand name OR generic name

9) manufacturer OR distributor
10) drug strength

11) contents in terms of: weight, measure, or numerical count

12) necessary auxiliary labels and storage instructions, if needed

13) MUST BE TYPED OR MACHINE PRINTED

Additional label requirements for controlled substances (Federal) - ANSWER 1)

date of initial dispensing

2) Transfer label: "Caution: Federal Law prohibits the transfer of this drug to any
person other than the person for whom it was prescribed."

EXCEPTION: C5's do NOT need transfer label.

Additional label requirements for controlled substances (Kansas) - ANSWER 1)

date of initial filling

Label requirements for PARENTERAL products (Federal) - ANSWER same as 1-6

in non-controlled federal section

1) name & address of pharmacy

2) serial number of prescription

3) date of prescription issuance or date filled

4) name of prescriber

5) name of patient, if stated

6) directions for use, including precautions, as indicated on the prescription

Label requirements for PARENTERAL products (Kansas) - ANSWER In

ADDITION to federal requirements, must include:

1) name & quantity of each drug and additive

2) "expiration date", meaning beyond-use date

3) prescribed flow rate

4) storage instructions, if applicable

*If dispensed in a MEDICAL CARE FACILITY, label ALSO requires:

1) date & time of addition of additives

2) name OR initials of person who prepared

Label requirements for prepackaged and repackaged drugs: - ANSWER 1) generic

name with manufacturer and distributor's name or the brand name

2) strength & quantity

3) lot number, date repackaged, and the person responsible for repackaging

4) expiration date, if applicable

5) auxiliary labels necessary

*Manufacturer, lot numbers, date repackaged, and the person responsible for
repacking MAY BE DELETED from the label if: a suitable record system is
maintained to indicate them.

time a pharmacist has to obtain the original prescription from a physician for an
emergency C2? - ANSWER 7 DAYS

allowable time to complete a C2 partial fill for a patient residing in a LONG-TERM

CARE FACILITY? - ANSWER within 60 DAYS of the date of issue

allowable time to complete a C2 partial fill for an AMBULATORY patient? -

ANSWER within 72 HOURS of the first partial fill

allowable number of times and/or length of time a pharmacist may refill a C3 or C4

prescription, if authorized? - ANSWER 6 MONTHS or 5 times, whichever comes
first

allowable number of times and/or length of time a Kansas pharmacist may refill a
C5 prescription, if authorized? - ANSWER 6 MONTHS or 5 times, whichever
comes first

Quantity of drug a pharmacist may dispense to a patient on an emergency C2

prescription? - ANSWER enough for the emergency period. not limited to a
specific number of doses
the controlled substance schedule of a preparation containing not more than 50
mg of morphine per 100 ml or per 100 grams combined with one or more active
non-narcotic agents. - ANSWER Schedule 3

A drug wholesaler, acting as a supplier, has how much time to complete a DEA
Form-222 before it becomes void? - ANSWER within 60 DAYS of the date of issue

what is the controlled substance schedule of buprenorphine Sublingual? -

ANSWER schedule 3

Pharmacist may sell no more than how many ml's or how many doses of a
codeine-containing C5 OTC in how many hours? - ANSWER 120 ml's or 24 doses,
in 48 HOURS

A C2 prescription is valid for how many months? (Kansas) - ANSWER 6 months

from date of issue

Allowable time to complete a partial refill on a C2 for a "terminally ill" patient? -

ANSWER 60 DAYS

Number of times a C2 prescription can be transferred? - ANSWER ZERO

Number of times a C3, 4, or 5 prescription (with refills) can be transferred in

Kansas if pharmacies do NOT share real-time computer system - ANSWER ONE

Number of days a physician may ADMINISTER methadone to a patient awaiting

admission at a narcotic treatment program? - ANSWER 3 days, one day at a time

The length of time a "DEA Dispenser" registration is valid? - ANSWER 3 years

length of time the pharmacist has to verify accuracy of the computer record for
filling/refilling C3 or C4 prescriptions? - ANSWER 72 HOURS

the maximum amount of codeine (mg) per dosage unit combined with one or
more active, non-narcotic ingredients to be scheduled as a C3? - ANSWER 90 mg

Maximum amount of pseudoephedrine base that may be sold to a purchaser in a

day - ANSWER 3.6 grams

a registrant transferring a pharmacy business operation to another registrant

must notify the nearest DEA office at least HOW MANY DAYS before the date of
the proposed transfer? - ANSWER 14 days

what schedule is oral diphenoxylate with atropine? - ANSWER C5

What is the minimum age of individuals allowed to purchase C5 OTC's in Kansas? -

ANSWER 18 years old

What is the allowable number of refills on phentermine prescribed for treatment

of obesity in Kansas? - ANSWER ZERO

following the initial CS inventory, a registrant must conduct the next CS inventory
within what time frame? In Kansas - ANSWER Within one year, must be at least 8
months after the initial inventory

Maximum number of doses (quantity) that may be prescribed and dispensed on a

SINGLE C2 prescription? - ANSWER No quantity limitation in either Kansas OR
Federal Law
Maximum number of days supply that may be prescribed and dispensed on
MULTIPLE C2 prescriptions? (Note: the multiple prescriptions will ALL have the
same date of issuance) - ANSWER 90 day supply

DEA form used by pharmacist to report theft or significant loss - ANSWER

DEA-Form 106

Maximum amount of pseudoephedrine that can be sold to a purchaser in 30 days -

ANSWER 9 grams (base)

Length of time a Kansas pharmacy must keep controlled substance records? -

ANSWER 5 years from the date of the last entry

How frequently must a community pharmacy submit dispensing data to KTRACS? -

ANSWER within 24 hours of being dispensed, unless exempted or filing a zero
report.

Length of time in which a pharmacy must notify the local DEA Diversion Field
Office after discovery of a theft or significant loss of controlled substances? -
ANSWER within ONE business day

DEA form used to report disposal or destruction of a controlled substance? -

ANSWER DEA-Form 41

the maximum amount of codeine (mg) per 100 ml or 100 g, combined with one or
more active, non-narcotic ingredients to be scheduled as a C5? - ANSWER 200 mg

A PIC must notify the Board in writing within how long of ceasing to serve as PIC? -
ANSWER 5 days
Within how many hours after becoming PIC, the PIC shall conduct a controlled
substance inventory? - ANSWER 72 hours

If a pharmacy operates for more than how many days without a designated PIC,
the Board may revoke, suspend, deny, or place their pharmacy registration in
probationary status? - ANSWER 30

Allowable purposes to prescribe amphetamines based on the board of healing

arts? - ANSWER 1) narcolepsy

2) drug-induced brain dysfunction

3) hyperkinesis

4) differential diagnostic psychiatric evaluation of depression

5) depression documented to be unresponsive to other forms of treatment

6) clinical investigation of drug effects (must have approval of board of healing

arts)

7) treatment of obesity with controlled substances, as may be defined by rules and

regulations

8) other disorders for which the drug is found to be useful (must have approval of
board of healing arts)

Treatment of Obesity - ANSWER 1) Amphetamines shall NOT be used to treat

obesity

2) physician must do full history, and recommend diet/exercise in addition.

3) **Can only prescribe 30 days of controlled substances at a time**

4) Physician may CONTINUOUSLY prescribe controlled substances for weight loss,

EXCEPT: if the patient has NOT lost at least 5% of initial weight during the initial
90 days of treatment using controlled substances.
Beyond-use date for non-sterile solid and liquid dosage forms packaged in
single-unit, unit-dose, or multi-unit containers - ANSWER Either

a) one year from date of repackaging/dispensing or

b) the manufacturer's expiration date.

Whichever is sooner

Beyond-Use Date for non-sterile compound (non-aqueous formulations) -

ANSWER a) 6 months or

b) earliest expiration date on any product included

Beyond-Use Date for non-sterile compound (water-containing oral formulations) -

ANSWER 14 days when stored at cold temperatures (36-46) (2-8 Celsius)

Beyond-Use Date for non-sterile compound (water-containing topical/dermal and

mucosal liquid and semisolid) - ANSWER 30 days

Official compendia of the US - ANSWER USP/NF

Durham-Humphrey Amendment of 1951 - ANSWER explicitly defined two specific

categories for medications, legend (prescription) and over-the-counter (OTC). Do
not need directions for use if they are "RX only".

FDCA defines a new drug as a previously approved drug entity with a new: -
ANSWER 1) route of administration

2) indication for use

3) combination of ingredients
Adulteration would include: - ANSWER 1) a drug prepared and packaged under
unsanitary conditions

2) the drug's manufacturing procedures do not conform to GMP standards

Misbranding would include: - ANSWER 1) a drug's label or labeling is false or

misleading

2) a prescription for a legend drug is refilled without the prescriber's authorization

3) a drug is subject to poison prevention act and is NOT packaged accordingly

The purpose of DESI was to prove efficacy of prescription and OTC drugs that were
marketed:

a. between 1938 and 1962.

b. before 1938.

c. after 1962.

d. none of the above. - ANSWER between 1938 and 1962

Preceptor must have how many years of experience? - ANSWER 2 years

Prescriptions in Kansas must be kept on file for how many years? - ANSWER 5
years

Incident reports must be kept on file for how many years in Kansas? - ANSWER 5
years

A pharmacist may not supervise more than how many pharmacy students or
interns at a time in Kansas? - ANSWER 2
Must be able to provide lot-level prescription product tracing for how long? -
ANSWER 6 years